| Name | QUAZEPAM |
| Synonyms | oniria quazium quazepam prosedar sch16134 dormalin QUAZEPAM Quazepam solution |
| CAS | 36735-22-5 |
| EINECS | 253-179-4 |
| Molecular Formula | C17H11ClF4N2S |
| Molar Mass | 386.79 |
| Density | 1.42±0.1 g/cm3(Predicted) |
| Melting Point | 137.5-139° |
| Boling Point | 429.9±55.0 °C(Predicted) |
| pKa | 0.49±0.20(Predicted) |
| Storage Condition | -20°C |
| Physical and Chemical Properties | The chemical properties are crystallized from dichloromethane-hexane with a melting point of 137.5~139 ℃. Acute toxic LD50 mice (mg/kg):>1370 intravenous injection,>5000 oral administration. Acute toxicity LD50 male and female mice, male and female rats (mg/kg):845,921,3072,2749 intraperitoneal injection. |
| Use | The use has the typical anti-anxiety, anti-convulsant and muscle relaxation effects of benzodiazepines, and the toxicity is very low. For all kinds of insomnia. |
| UN IDs | 3249 |
| HS Code | 2933996500 |
| Hazard Class | 6.1(b) |
| Packing Group | III |
| Toxicity | LD50 in mice (mg/kg): >1370 i.v., >5000 orally (Orgini); LD50 in male, female mice, rats (mg/kg): 845, 921, 3072, 2749 i.p. (Black) |